top of page

OUR TECHNOLOGY

Bacteriophages (Phages):

Bacteriophages are naturally occurring viruses that interact specifically with certain types of bacteria. They are widely present in the environment, including soil, water, and biological ecosystems.

  1. Phages are characterized by their specificity toward particular bacterial strains.

  2. They are commonly found in natural environments and microbiological systems.

  3. Phages are safe and interact with bacterial cells and do not target animal or human cells.

  4. Bacteriophage-based technologies are being studied and developed for controlled applications within regulated agricultural, environmental, and production systems.

Mode of Action of Bacteriophages

Lytic phages are more effective as they cause lysis of targeted bacteria

Introduction to our Peptide Technology

Peptides produced by certain bacterial strains are commonly referred to as bacteriocins.

  • Bacteriocins are naturally occurring peptides produced by certain bacteria as part of microbial ecological interactions.

  • Both Gram-positive and Gram-negative bacteria produce a variety of bacteriocins, which can influence interactions among susceptible bacterial populations.

  • InnovaPeptide® consists of small biological cationic molecules (<10 kDa) characterized by defined net charge, hydrophobicity, and secondary structure. These physicochemical properties enable interaction with bacterial cell membranes and cellular components.

  • The mechanisms associated with these peptides include membrane-level interaction and receptor-mediated processes at the bacterial cell surface.

  • Due to their targeted interaction patterns, these peptides are studied for their role in controlled microbial management systems.

  • The proprietary formulation of InnovaPeptide® is designed to support structural stability under defined processing and application conditions.

Biopeptides in Comparison to Conventional Antibiotic Approaches

Virus Inhibitor Technologies

Viral Challenges in Livestock Production

Viral diseases in livestock present ongoing challenges for animal production systems, food supply stability, and economic performance.

Various antiviral strategies, including interferon-based and synthetic approaches, are recognized within regulated veterinary and research contexts.

Innova Biotechnology develops viral inhibitor platforms and bioactive technologies designed for integration into controlled agricultural and production systems in accordance with applicable regulatory frameworks.

Interferons (INFs)

infs-removebg-preview.png

Characteristics

  • Types: Type I (e.g., IFN-α, IFN-β), Type II (IFN-γ), and Type III (IFN-λ).

  • Source: Produced by host cells as part of natural cellular response mechanisms.

  • Structure: Glycoproteins exhibiting species-specific biological activity.

Mode of Action

Signal Transduction: Interferons bind to specific cell-surface receptors and initiate intracellular signaling cascades, including activation of the JAK-STAT pathway. This signaling leads to transcriptional activation of interferon-stimulated genes (ISGs), which are involved in cellular response regulation.

Antiviral Effects:

Expression of ISGs is associated with:

  • Regulation of viral entry-related processes (e.g., IFITM family proteins)

  • RNA processing pathways (including OAS-related mechanisms)

  • Modulation of protein synthesis pathways (e.g., PKR-associated signaling)

  • Regulation of programmed cellular response mechanisms

Immunomodulation: Enhance antigen presentation, activate NK cells and macrophages.

Applications in Livestock

  • Used in cattle, swine, and poultry to reduce viral load and enhance resistance.

  • Administered prophylactically or therapeutically

bottom of page